© 1986 Oxford University Press
research-article |
Changes in nuclear protein acetylation in u.v.-damaged human cells
Biochemistry/Biophysics Program, Washington State University Pullman, WA 99164–4660, USA
We have investigated the levels of nuclear protein acetylation in u.v.-irradiated human fibroblasts. Initially, we measured the levels of acetylation in total acid-soluble nuclear proteins and observed two distinct differences between the irradiated and unirradiated (control) cells. Immediately after irradiation, there is a ‘wave’ of protein hyperacetylation (i.e. a total acetylation level greater than that of unirradiated cells) that lasts for 2–6 h depending on the experimental conditions. This hyperacetylation phase is then followed by a hypoacetylation phase, lasting for many hours, and the total level of acetylation does not return to that of control cells until 24–72 h after u.v. damage. Both the magnitude and duration of each phase is dependent on the dose of u.v. light used. The wave of hyperacetylation is more pronounced at low u.v. doses (i.e. <5 J/m2), while the wave of hypoacetylation is more pronounced at higher u.v. doses (>8 J/m2). Furthermore, the duration of each phase is prolonged when cells are exposed to 2 mM hydroxyurea, an agent which retards the rate of excision repair at u.v.-damaged sites. Examination of the acetylation levels of the individual nuclear proteins indicated that acetylation of the core histories follows the same pattern observed for the total acid-soluble protein fractions. Furthermore, these were the only major proteins in the total acid-soluble fraction observed to undergo the early, rapid hyperacetylation immediately following u.v. damage. Acetylation of histone HI was negligible in both damaged and control cells, while three prominent non-histone proteins were acetylated only after long labeling times (>4 h) in each case, gradually becoming hyperacetylated in the u.v.-damaged cells. These results raise the possibility that a causal relationship exists between nuclear protein acetylation and nucleotide excision repair of DNA in human cells.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Q. Zhao, B. M. Barakat, S. Qin, A. Ray, M. A. El-Mahdy, G. Wani, E.-S. Arafa, S. N. Mir, Q.-E. Wang, and A. A. Wani The p38 Mitogen-activated Protein Kinase Augments Nucleotide Excision Repair by Mediating DDB2 Degradation and Chromatin Relaxation J. Biol. Chem., November 21, 2008; 283(47): 32553 - 32561. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Lange, D. L. Mitchell, and K. M. Vasquez High mobility group protein B1 enhances DNA repair and chromatin modification after DNA damage PNAS, July 29, 2008; 105(30): 10320 - 10325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wang, M. Y. Chin, and G. Li The Novel Tumor Suppressor p33ING2 Enhances Nucleotide Excision Repair via Inducement of Histone H4 Acetylation and Chromatin Relaxation Cancer Res., February 15, 2006; 66(4): 1906 - 1911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Allison and J. Milner Remodelling chromatin on a global scale: a novel protective function of p53 Carcinogenesis, September 1, 2004; 25(9): 1551 - 1557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Allison and J. Milner Loss of p53 Has Site-Specific Effects on Histone H3 Modification, Including Serine 10 Phosphorylation Important for Maintenance of Ploidy Cancer Res., October 15, 2003; 63(20): 6674 - 6679. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Choy and S. J. Kron NuA4 Subunit Yng2 Function in Intra-S-Phase DNA Damage Response Mol. Cell. Biol., December 1, 2002; 22(23): 8215 - 8225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Carrier, P. T. Georgel, P. Pourquier, M. Blake, H. U. Kontny, M. J. Antinore, M. Gariboldi, T. G. Myers, J. N. Weinstein, Y. Pommier, et al. Gadd45, a p53-Responsive Stress Protein, Modifies DNA Accessibility on Damaged Chromatin Mol. Cell. Biol., March 1, 1999; 19(3): 1673 - 1685. [Abstract] [Full Text] [PDF]
|
|